World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
52
Citations
12956
World Ranking
5239
National Ranking
2343

Smriti Iyengar publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Smriti Iyengar sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 138 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Smriti Iyengar D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Smriti Iyengar sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 52 D-Index — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Smriti Iyengar is affiliated with Eli Lilly in the United States and has contributed extensively to the field of medicine with a strong focus on pain research. Their work spans several subfields, including physiology, anesthesiology and pain medicine, public health, environmental and occupational health, pharmacology, and economics and econometrics.

Their research interests primarily cover topics related to pain mechanisms and treatments, pain management and opioid use, health systems, economic evaluations and quality of life, musculoskeletal pain and rehabilitation, placebo effects in pain management, animal testing and alternatives, and opioid use disorder treatment.

Frequent publication venues for Iyengar include:

  • Pain
  • Journal of Pain
  • Neurotherapeutics
  • Nature Reviews Neurology
  • EClinicalMedicine

Among their recent publications are:

  • "Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities," 2020, Nature Reviews Neurology
  • "Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations," 2020, Pain
  • "Developing consensus on core outcome sets of domains for acute, the transition from acute to chronic, recurrent/episodic, and chronic pain: results of the INTEGRATE-pain Delphi process," 2023, EClinicalMedicine
  • "Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations," 2021, PAIN Reports
  • "Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statement," 2023, Pain

Co-authors frequently collaborating with Iyengar include:

  • Sarah A. Woller
  • Dennis C. Turk
  • Robert H. Dworkin
  • John T. Farrar
  • Penney Cowan

Smriti Iyengar's research consolidates multidisciplinary approaches to understanding and managing pain through both clinical and public health perspectives. Their work contributes to improving methodologies for pain assessment and treatment, including developing core outcome sets and research design recommendations for clinical trials in pain therapeutics.

Best Publications

  • Duloxetine vs. placebo in patients with painful diabetic neuropathy.

    David J. Goldstein;Yili Lu;Michael J. Detke;Michael J. Detke;Thomas C. Lee

  • A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.

    Lesley M. Arnold;Yili Lu;Leslie J. Crofford;Madelaine Wohlreich

  • A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.

    Joel Raskin;Yili L. Pritchett;Fujun Wang;Deborah N. D'Souza

  • A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.

    Lesley M. Arnold;Amy Rosen;Yili Lu Pritchett;Deborah N. D'Souza

  • A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain

    J. F. Wernicke;Y. L. Pritchett;D. N. D’Souza;A. Waninger

  • The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine.

    Smriti Iyengar;Michael H. Ossipov;Kirk W. Johnson

  • CGRP and the Trigeminal System in Migraine.

    Smriti Iyengar;Kirk W. Johnson;Michael H. Ossipov;Sheena K. Aurora

  • Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities.

    Karen D. Davis;Karen D. Davis;Nima Aghaeepour;Andrew H. Ahn;Martin S. Angst

  • Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats

    Smriti Iyengar;Amy A Webster;Susan K Hemrick-Luecke;Jimmy Yu Xu

  • Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial.

    Amy S. Chappell;Melissa J. Ossanna;Hong Liu-Seifert;Smriti Iyengar

  • Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations

    Dennis C. Turk;Robert H. Dworkin;Michael P. McDermott;Nicholas Bellamy

  • Efficacy and safety of duloxetine in patients with chronic low back pain.

    Vladimir Skljarevski;Durisala Desaiah;Hong Liu-Seifert;Qi Zhang

  • Depression and pain.

    Michael J. Robinson;Sara E. Edwards;Smriti Iyengar;Frank Bymaster

  • Inhibition of Nitric Oxide Synthase Blocks N‐Methyl‐D‐Aspartate‐, Quisqualate‐, Kainate‐, Harmaline‐, and Pentylenetetrazole‐Dependent Increases in Cerebellar Cyclic GMP In Vivo

    Paul L. Wood;Mark R. Emmett;Tadimeti S. Rao;Julie Cler

  • Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat.

    Rosa Maria A. Simmons;Dominic L. Li;Ken H. Hoo;Michelle Deverill

  • Effects of Duloxetine on Painful Physical Symptoms Associated With Depression

    David J. Goldstein;Yili Lu;Michael J. Detke;James Hudson

  • Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats.

    Rosa Maria A. Simmons;Amy A. Webster;Anshu B. Kalra;Smriti Iyengar

  • The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.

    Frank P. Bymaster;Thomas C. Lee;Mary Pat Knadler;Michael J. Detke

  • Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain: Evidence-Based Findings from Post Hoc Analysis of Three Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Studies

    Daniel K. Kajdasz;Smriti Iyengar;Durisala Desaiah;Misha Miroslav Backonja

  • Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials.

    Lesley M. Arnold;Yili Lu Pritchett;Deborah N. D'Souza;Daniel K. Kajdasz

  • Review and recommendations Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations

    Dennis C. Turk;Robert H. Dworkin;Michael P. McDermott;Nicholas Bellamy

Frequent Co-Authors

Lino Becerra
Lino Becerra Harvard Medical School
David Borsook
David Borsook Boston Children's Hospital
Richard Hargreaves
Richard Hargreaves Harvard Medical School
Robert H. Dworkin
Robert H. Dworkin University of Rochester Medical Center
Michael P. McDermott
Michael P. McDermott University of Rochester
John T. Farrar
John T. Farrar University of Pennsylvania
Paul L. Ornstein
Paul L. Ornstein Eli Lilly and Company
Dennis C. Turk
Dennis C. Turk University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Neuroscience opens doors to a variety of related fields and professional pathways. Many students combine their neuroscience background with further online education in psychology, social work, or therapy to boost career versatility and prospects.

If you’re interested in mental health counseling, consider a marriage and family therapy degree online. This pathway is ideal for those who aspire to support families and couples through mental and emotional challenges.

For broader psychological expertise, an masters of psychology online can deepen your grasp of human behavior and open doors to research, teaching, or clinical careers. There are also many cheapest online psychology degree programs available for students seeking affordable entry points into the field.

Those hoping to work in community care or clinical settings may be drawn to social work. The msw degree prepares graduates for impactful work in schools, hospitals, and non-profit organizations.

Exploring these related online degrees can help neuroscience graduates tailor their education to meet their career goals and adapt to the evolving demands of the workforce.

Best Scientists Citing Smriti Iyengar

Trending Scientists

Recently Published Articles